Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
North America is the largest supplier of Plasma Fractionation, with production revenue market share about 60%, and the sales market share is 44% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
Europe, following North America, takes production revenue market share of 20% and the sales market share over 20% in 2015. China is an important market of Plasma Fractionation in Asia, accounting for 11% production revenue market share and 12% sales revenue market share of global market in 2015.
Japan has production revenue market share of 5% and sales revenue market share of 7% nearly in 2015. The local production can meet most local demand, and there is a small amount of imports.
Baxter, CSL, Grifols are the leaders of the industry, with 65% market share in 2015, and hold key technologies and patents. Other manufactures' products are used to meet local demand. With further expanding market, there will be more players in the future.



According to this study, over the next five years the Plasma Fractionation market will register a 10.6% CAGR in terms of revenue, the global market size will reach US$ 52800 million by 2024, from US$ 28900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Plasma Fractionation business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Fractionation market by product type, application, key manufacturers and key regions and countries.

This study considers the Plasma Fractionation value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
Albumin
Immune Globulin
Coagulation Factor
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
Immunity
Therapy
Surgery
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Plasma Fractionation consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Plasma Fractionation market by identifying its various subsegments.
Focuses on the key global Plasma Fractionation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plasma Fractionation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Plasma Fractionation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.